Developing vaccines to counter bioterrorist threats.
Large and innovative research programs are underway to define the immune parameters for vaccines against a wide array of pathogens considered to represent a potential bioterrorist threat. However, the development and utilization of such vaccines presents a number of predicaments that have not previously been addressed by the field of vaccinology.
Altmann
Daniel M
DM
Department of Infectious Diseases, Imperial College, Hammersmith Hospital, London, W12 0NN, UK. d.altmann@ic.ac.uk
D000818:Animals; D001694:Biological Warfare / Q000517:prevention & control / Q000639:trends; D023482:Bioterrorism / Q000517:prevention & control* / Q000639:trends; D006801:Humans; D013678:Technology, Pharmaceutical / Q000379:methods / Q000639:trends*; D014612:Vaccines / Q000138:chemical synthesis / Q000627:therapeutic use*; D019444:Vaccines, DNA / Q000138:chemical synthesis / Q000627:therapeutic use
D014612:Vaccines; D019444:Vaccines, DNA